Risk of progression of Barrett's esophagus in patients with cirrhosis

Table 2 Patient characteristics: Non-cirrhotic vs cirrhotics n (%)

	No Cirrhosis(n = 228)	Cirrhosis(n = 57)	P value
Male	180 (78.9)	45 (78.9)	0.99
Age at BE (yr)	59.1 ± 9.6	58.9 ± 9.6	0.51
Body mass Index (kg/m2)	30.3 ± 6.0	30.6 ± 7.1	0.10
Ethnicity			0.97
Caucasian	214	54
African-American	3	1
Other	7	0
BE Length (cm)	2.7 ± 3.1	3.5 ± 3.4	0.20
Presence of hiatal hernia	128 (56.1)	9 (16.1)	< 0.0011
Hiatal hernia length (cm)	3.2 ± 1.5	3.6 ± 1.01	0.31
Baseline biopsy			0.10
No dysplasia	155 (68.0)	45 (78.9)
Low grade Dysplasia	28 (12.3)	5 (8.8)
High grade Dysplasia	29 (12.7)	5 (8.8)
Esophageal adenocarcinoma	16 (7.0)	2 (3.5)
Number of endoscopies	3 (2, 6)	2 (2, 4)	0.0091
Follow-up endoscopy (mo)	36.3 (13.6, 77.3)	31.9 (12.5, 57.3)	0.15

¹Statistically significant; Statistics presented as mean ± SD, Median (P25, P75) or n (%).